PT-141, also known as Bremelanotide, is a synthetic cyclic heptapeptide derived from alpha-melanocyte-stimulating hormone (α-MSH). It functions as a melanocortin receptor agonist, with activity primarily at the MC3R and MC4R receptors. Researchers continue to investigate PT-141 across laboratory models involving melanocortin signaling, neuroendocrine physiology, central nervous system communication, receptor pharmacology, peptide biology, and molecular signaling.
Our PT-141 research peptide is manufactured under stringent quality standards and supplied exclusively for laboratory and analytical research purposes. Every vial is produced to support consistent, reproducible scientific investigations.
